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Abstract
Toxoplasmosis, caused by the apicomplexan parasite Toxoplasma gondii, is one of the most common infections in the world 
due to the lifelong persistence of this parasite in a latent stage. This parasite hijacks host signaling pathways through epi-
genetic mechanisms which converge on key nuclear proteins. Here, we report a new parasite persistence strategy involving 
T. gondii rhoptry protein ROP16 secreted early during invasion, which targets the transcription factor UHRF1 (ubiquitin-
like containing PHD and RING fingers domain 1), and leads to host cell cycle arrest. This is mediated by DNMT activity 
and chromatin remodeling at the cyclin B1 gene promoter through recruitment of phosphorylated UHRF1 associated with a 
repressive multienzymatic protein complex. This leads to deacetylation and methylation of histone H3 surrounding the cyclin 
B1 promoter to epigenetically silence its transcriptional activity. Moreover, T. gondii infection causes DNA hypermethyla-
tion in its host cell, by upregulation of DNMTs. ROP16 is already known to activate and phosphorylate protective immunity 
transcription factors such as STAT 3/6/5 and modulate host signaling pathways in a strain-dependent manner. Like in the 
case of STAT6, the strain-dependent effects of ROP16 on UHRF1 are dependent on a single amino-acid polymorphism in 
ROP16. This study demonstrates that Toxoplasma hijacks a new epigenetic initiator, UHRF1, through an early event initiated 
by the ROP16 parasite kinase.
Keywords Toxoplasma gondii · UHFR1 · ROP16 · Cyclin B1 · DNMT · Epigenetic regulation
Introduction
Toxoplasmosis, caused by the intracellular apicomplexan 
parasite Toxoplasma gondii is one of the most common 
infections in the world, leading to a lifelong latent infection 
due to the persistence of the parasites within cysts in spe-
cific host organs like the brain, the muscles or the eye [1]. 
While generally asymptomatic, the infection can be severe 
in case of primary infection during pregnancy or reactivation 
in immunosuppressed individuals. There is neither efficient 
treatment against the latent parasite forms nor a vaccine.
A particularity of T. gondii is the existence of numerous 
strains with different geographical distribution and strikingly 
different virulence. Originally, three major lineages had been 
described in Europe and North America, with type I strains 
being highly virulent in mouse infections, while type II and 
III strains showed moderate virulence [2]. More recently, 
genetic examination of 958 strains collected from around 
the world classified them into 15 haplogroups within 6 major 
clades [3].
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To achieve intracellular persistence, T. gondii modulates 
and hijacks host cell pathways involved in various pro-
cesses such as inflammation, apoptosis, metabolism, and 
cell growth [4]. This prevents infected cells from apoptosis 
and subverts the host’s immune system [5, 6]. The parasite 
manipulates the host cell signaling pathways by secreting 
kinases and phosphatases, of which some infiltrate the host 
cell nucleus and modulate gene expression activity. ROP16, 
a T. gondii protein kinase secreted during early stages of 
invasion, has been described to activate and phosphorylate 
immune-related transcription factors such as STAT 3/5/6 
and modulate host signaling pathways in a strain-depend-
ent manner [7–10]. Our recent results in a mouse model 
of ocular toxoplasmosis showed the capacity of ROP16 to 
influence cytokine expression and parasite control in vivo 
[11], demonstrating its biological importance and need to 
elucidate its effects on a cellular level. Toxoplasma strain-
dependent effects on host factors have also been reported 
for ROP18, GRA15 and other effectors [8, 12]. For STAT3, 
the strain dependence of ROP16 action is determined by a 
single amino-acid polymorphism [13].
These changes in host genome activity imply modifying 
the epigenome of the host cell [14]. Until now, only few 
Toxoplasma proteins have been described as able to trig-
ger the initial epigenetic signal: the rhoptry protein ROP18, 
as well as the dense granule proteins GRA15, GRA16 and 
probably GRA24 [4, 15–17]. Toxoplasma is able to imprint 
epigenetic marks on the host cell genome. Thus, the para-
site prevents histone H3 phosphorylation and acetylation at 
the TNFA and IL10 promoters [18, 19]. Similarly, severely 
impaired histone acetylation at IFN-γ-regulated promot-
ers during infection, and a parasite-mediated defect in the 
recruitment of chromatin remodeling complexes have been 
reported [14, 20]. Decreased promoter methylation, through 
DNA methyltransferase activity has been shown to increase 
gene expression of neurons in Toxoplasma-infected rats [21].
CpG methylation by the DNA methyltransferases, 
DNMT1 and DNMT3a/b, and histone modifications are 
two major components of the epigenetic regulation. Tran-
sition from an active to an inactive state of transcription 
requires a series of coordinated modifications on histone 
residues. They are catalyzed by specific enzymes, but even 
their intrinsic affinity for their substrates is insufficient 
to explain their high site specificity in inducing chroma-
tin modifications. UHRF1 (ubiquitin-like containing PHD 
and RING finger domain 1) plays a major role in the read-
ing and inheritance of epigenetic code due to its ability to 
recruit effectors catalyzing these marks [22–25]. UHRF1 is 
an important epigenetic regulator with different structural 
domains: an N-terminal ubiquitin-like (UbL) domain, a 
tandem tudor (TTD) domain, a plant homeodomain (PHD), 
a SET and RING (really interesting new gene)-associated 
(SRA) domain. These domains are associated with binding 
to methylated DNA (SRA domain), histones (TTD and 
PHD domains) and epigenetic effectors (SRA, TTD, PHD 
domains) [24]. UHRF1 and the associated proteins play a 
central role in epigenetic modifications such as DNA meth-
ylation and histone modifications. Indeed, UHRF1 is asso-
ciated with maintenance of DNA methylation patterns by 
recruiting DNMT1 to hemi-methylated CpG, and histone 
modifications by interacting with HDAC1 and DNMT1 [23, 
25, 26]. UHRF1 coordinates epigenetic silencing of tumor 
suppressor genes and plays a key role in cell cycle, epige-
netic regulation in the development and progression of can-
cers and metastasis [24, 27].
We have previously shown that both cyclin B1 mRNA 
and protein are downregulated in T. gondii-infected cells, 
resulting in dissociation of the cyclin B1/Cdk1 complex, 
which is necessary for the G2/M transition. We also found 
that infection-induced upregulation of UHRF1 expression 
is responsible for the host cell arrest at the G2 phase and is 
essential for parasite proliferation [28]. ROP16 was reported 
to interact with p53 resulting in G1 cell cycle arrest [29].
Here, we report a new parasite strategy involving ROP16 
which targets UHRF1. This event prevents chromatin remod-
eling at the cyclin B1 gene (CCNB1) promoter through 
recruitment of phosphorylated UHRF1 associated to a 
repressive multienzymatic complex. This leads to deacetyla-
tion and methylation of histone H3 surrounding the CCNB1 
promoter to epigenetically silence its transcriptional activity. 
Moreover, T. gondii infection causes DNA hypermethyla-
tion in its host cell by upregulation of DNMTs. This study 
demonstrates that Toxoplasma hijacks another epigenetic 
initiator, UHRF1, through an early event initiated by the 
ROP16 kinase.
Materials and methods
Cells and parasites
The human trophoblast cell line BeWo was obtained from 
the American Type Culture Collection (Mannassas, VA) 
and cultured in FK12 medium (Fisher Scientific, Illkirch-
Graffenstaden, France), supplemented with 10% heat inac-
tivated FCS (Invitrogen, Cergy Pontoise, France), 10 U/ml 
penicillin, 10 µg/ml streptomycin (Invitrogen). The human 
astrocytic cell line U-118MG was cultured in DMEM 
medium (Fisher Scientific), supplemented as above plus 
2 mM glutamine. Cell cultures were kept at 37 °C, 5% CO2 
and cell numbers were determined with a Neubauer cell 
counting chamber using a Trypan blue (Corning, Corning 
NY) exclusion test.
The virulent RH T. gondii strain was originally obtained 
from the French Biological Resource Center Toxoplasma 
(CRB Toxoplasma; Laboratoire de Parasitologie, CHU 
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Reims, France). The RHΔROP16 strain was kindly provided 
by J. Boothroyd, Stanford University. Preliminary assays 
showed similar parasite proliferation and UHRF1 regula-
tion of the RH and the RHΔKU80 strain, which was used to 
create the KO strain. RH parasites were thus used as control 
strain. Tachyzoites were maintained in human THP1 mono-
cyte cultures or by weekly passages in Swiss Webster mice. 
Before use, they were washed twice in PBS and counted 
using Trypan blue exclusion test.
To create ROP16 mutant plasmids, the coding region of 
ROP 16 was amplified by PCR on genomic DNA from the 
RH, PRU and LEF strains using primers 5′-CGG AAT TCA 
TGA AAG TGA CCA CGA -3′ and 5′-CGC TCT AGA CTA CAT 
CCG ATG TGA AG -3′ including the EcoRI and BglII restric-
tion sites. An amplified fragment of 2124pb was purified and 
inserted into the cloning vector  pGEMT® (Promega) by liga-
tion after A-tailing. PGEMT-ROP 16 was digested by EcoRI 
and BglII restriction enzymes and cloned in pCDNA3-HA 
vector (Invitrogen).
The mutant plasmid ROP16ΔCat, deficient for the kinase 
catalytic domain was generated using the a site-directed 
mutagenesis kit (Stratagene, San Diego, USA) on the expres-
sion vectors containing the wild-type gene of ROP16 The 
primers used were sense 5′-GAG TGC CGA TCG CTC AGC 
AAG CCC CTGG-3′ and antisense 5′-CCA GGG GCT TGC 
TGA GCG ATC GGC ACTC-3′. The mutants L503S for RH 
and LEF strains and S503L for PRU were likewise gener-
ated, using the primers (L503S) sense 5′ CCA TTA ATT 
GAT GGC TCC GCA TCG AAC AGT CTA GTC CAG 
TC 3′; antisense 5′ GAC TGG ACT AGA CTG TTC GAT 
GCG GAG CCA TCA ATT AAT GG 3′ and (S503L) sense 
5′ CCA TTA ATT GAT GGC TCC CCA TTG AAC AGT 
CTA GTC CAG TC 3′; antisense 5′ GAC TGG ACT AGA 
CTG TTC AAT GGG GAG CCA TCA ATT AAT GG 3′.
Transfection of host cells and luciferase assays
The corresponding nucleotides of UHRF1 were cloned into 
a siRNA expression vector, psiU6BX3, constructed as pre-
viously described [30]. A EGFP-siRNA or UHRF1-siRNA 
(si-3: 2123–2141) plasmid construct was transfected to 
cells for 24 h and incubated with 900 µg/ml of G418 for 
a further 48 h before infection with T. gondii as indicated 
in the figure legends. Cells were then harvested for West-
ern blotting. pGL3-UHRF1-Luc plasmids were generously 
donated by M. Unoki, University of Tokyo, Japan. BeWo 
cells were transfected with plasmids (2 µg/well) for 24 h 
with X-tremeGENE™ (Sigma-Aldrich, Saint-Quentin-Falla-
vier, France) transfection reagent and infected with T. gondii 
for the indicated times and harvested for luciferase activity 
measurements with 250 µL of Bright-Glo luciferase assay 
Buffer (Promega, Charbonnières-les-Bains, France). Results 
are expressed as a ratio of the protein quantification, as our 
preliminary tests showed that the protein masses of the para-
sites are negligible compared to the cell protein contents.
Chemicals and antibodies
Polyclonal anti-T. gondii antibody was raised in New Zea-
land rabbits by several injections of 50 µg of soluble T. gon-
dii antigen suspended in Freund’s incomplete adjuvant. The 
IgG fraction of this serum was purified by chromatography 
on DEAE Trisacryl (l M) and tested by ELISA. The mouse 
monoclonal antibody against UHRF1 (clone 1RC1C-10) was 
engineered as described elsewhere [28]. The anti-cyclin B1, 
anti-p-Ser and anti-actin mouse monoclonal antibodies or 
anti-DNMT1 rabbit polyclonal antibody were obtained from 
Santa Cruz Biotechnology (Santa Cruz, CA).
Alexa Fluor 488 goat anti-rabbit IgG was obtained from 
Invitrogen (Carlsbad, CA).
Goat F(ab’)2 fragment anti-mouse IgG-peroxidase, don-
key F(ab’)2 fragment anti-rabbit IgG-peroxidase, Tween-
20 and the protease inhibitor cocktail were purchased from 
Roche Diagnostics (Basel, Switzerland). G 418 was pur-
chased from Sigma-Aldrich (Saint-Louis, MO).
The ECL detection system was obtained from Amersham 
Biosciences (GE Healthcare Europe GmbH, Orsay, France). 
TriReagent was purchased from Molecular Research Center 
(Cincinnati, OH).
Flow cytometry
BeWo cells were grown in six-well plates (Dutscher, Bru-
math, France) and infected at sub-confluent conditions with 
T. gondii for the indicated times at 37 °C. The cells were 
harvested by trypsinization (Fisher Scientific) and gently 
washed three times with 1 ml of PBS. Cell suspensions 
were fixed by incubation for 15 min on ice in 0.4 ml of 5% 
formaldehyde in PBS (v/v), washed with PBS; then resus-
pended in 1 ml of absolute ethanol and stored at − 20 °C 
until use. Infected cells were identified by flow cytometry. 
Briefly, cells were washed and stained for 45 min with rabbit 
anti-T. gondii IgG antibody. Then, samples were washed and 
incubated with Alexa Fluor 488 goat anti-rabbit for 45 min 
and washed again. DNA labeling was obtained by incuba-
tion for 2 h with 50 μg/ml of propidium iodide and 50 μg/
ml of RNAse A (Euromedex, Souffelweyersheim, France) at 
room temperature in the dark. Fluorescence was measured 
in a FACScan flow cytometer (Becton–Dickinson, Frank-
lin Lakes, NJ) and analyzed with the CellQuest software 
package.
Western blotting and co‑immunoprecipitation
Whole cell extracts were prepared as described elsewhere 
[30]. Blots were probed with the indicated antibodies at 
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1 µg/ml. For co-immunoprecipitation of UHRF1, infected 
or uninfected cell extracts were incubated with protein G 
beads coupled to anti-UHRF1 monoclonal antibody (5 µg) 
in 1 ml PBS supplemented with protease inhibitors for 2 h 
at 4 °C. Beads were washed five times with PBS and bound 
proteins were removed from the beads, denatured using load-
ing buffer and separated on 10% SDS-PAGE gels, blotted 
and finally probed with 1 µg/ml of antibodies. Secondary 
peroxidase conjugated antibodies were used at 0.16 µg/ml. 
Signals were visualized by chemiluminescence using the 
ECL detection system.
Proteomics
Samples were separated on a 10% SDS-PAGE gel stained 
with Coomassie blue. After migration, each line was cut 
every 2 mm and the gel plugs transferred into a 96-well 
plate.
In-gel digestion was performed with an automated pro-
tein digestion system, a MassPrep Station (Waters, Man-
chester, U.K.). The gel plugs were washed twice with 50 
µL of 25 mM ammonium hydrogen carbonate and 50 µL of 
acetonitrile. The cysteine residues were reduced by addition 
of 10 mM dithiothreitol at 60 °C and alkylated by addi-
tion of 50 µL of 55 mM iodoacetamide. After dehydration 
with acetonitrile, the proteins were cleaved in gel with a 
12.5 ng/µL solution of modified porcine trypsin (Promega, 
Madison, WI) in ammonium hydrogen carbonate (≈ 15 µL). 
The digestion was performed overnight at 37 °C. Tryptic 
peptides were extracted twice: with 40 µL of a 60/40/0.1 
ACN/H2O/HCOOH solution for 1 h and with 40 µL of pure 
ACN. The collected extracts were pulled and evaporated to 
10 µL with a vacuum centrifuge  (Speedvac®, Thermo Savant 
SPD111 V, Waltham, MA, USA).
For MS analysis, each sample was analyzed on a nano-
Acquity™ (Waters, Manchester, U.K.) coupled to a Synapt 
G1 (Waters, Manchester, U.K.), which was equipped with a 
nanoelectrospray ion source. Peptide separation was carried 
out on a RP-HPLC column C18 (75 µm × 200 mm length 
nanoAcquity™UPLC™, porosity 1.7 µm). The gradient was 
performed by a mix of two solvents A (0.1% formic acid 
in water) and B (0.1% formic acid in acetonitrile). Separa-
tion was performed at 300 nL/min flow rate using a 35 min 
gradient from 10 to 40% B. The capillary, sample cone and 
extraction cone voltages were set to 3000 V, 35 V and 40 V, 
respectively. The temperature of the source was set to 90 °C.
Mass calibration was achieved using the fragmenta-
tion of glyco-fibrin peptide over the range 250–2000 Da. 
Acquisition was performed with the Masslynx software 
4.1. (Waters, Manchester, UK). The MS survey scan was 
acquired on the range m/z 250–1500 with a scan time of 
0.5 s. The five most intense ions of the MS spectra were 
selected for MS/MS (intensity threshold 20 counts). CID 
fragmentation was performed using argon as collision gas 
and with collision energy profile optimized for various 
mass ranges of precursor ions. The scan range for MS/
MS acquisition was from m/z 50 to 2000 Da with a scan 
time of 0.8 s. If the intensity of the MS/MS was less than 
4500 cps, the MS/MS scan lasted 2.3 s. A selected ion is 
excluded for 4 s after the selection.
Data collected during a nanoLC-MS/MS analysis were 
automatically processed and converted into a.pkl file using 
ProteinLynx Browser 2.3 (Waters, Manchester, U.K.). 
These files were then submitted to Mascot (Matrix Sci-
ence, London, U.K.) against a mixed human (Swiss prot, 
23/02/2012) and toxo (Toxodb, vr6.3, 22/01/2011) decoy 
database (88 468 entries). Searches were performed with a 
tolerance on mass measurement of 15 ppm for the precur-
sor and 0.07 Da on the fragments. Carbamidomethylation 
of cysteine residues and oxidation of methionine residues 
were searched as variable modifications. Up to one missed 
cleavage was allowed.
Scaffold 3.00.03 (Proteome Science, Portland, Oregon) 
was used for identification validation and false positive 
rate estimation for protein identification. Selection filters 
were applied to obtain a false positive rate (FDR) less than 
1%. Seven proteins of interest were selected, MS/MS spec-
tra extracted and manually verified. These seven proteins 
of interest were then validated by immunoprecipitation.
Quantitative PCR and RT‑PCR analysis
Cells were cultured in six-well plates, infected with T. gon-
dii for the indicated times and lysed with TriReagent. 
Total RNA was extracted according to the manufacturer’s 
recommendations. 5 µg of RNA were then reverse tran-
scribed using qScript cDNA Synthesis Kit (Quantabio). 
Primers were used at a final concentration of 0.5 µM: glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH, 137 bp) 
sense 5′-AGC AAT GCC TCC TGC ACC ACC AAC-3′; 
antisense 5′-CCG GAG GGG CCA TCC ACA GTCT-
3′; DNMT1 (144 bp) sense 5′- AGG ACA GGG GAC CCA 
CGA AA-3′; antisense 5′- ACA CCT CAC AGA CGC CAC 
AT-3′; UHRF1 (240 bp) sense 5′- GGG GCT ATG AGG 
ATG ATG TG-3′; antisense 5′-TCT TGC CAC CCT TGA 
CAT T-3′. Quantification of transcripts was performed by 
an external standard curve. Real-time PCR was carried out 
on the CFX Connect™ Real-Time PCR detection system 
(Bio-Rad, Marnes la Coquette, France) using the SsoAd-
vanced™ Universal  SYBR® Green Mix (Bio-Rad). After 
30 s of denaturation at 95 °C, the reaction was cycled 40 
times, 10 s at 95 °C, 10 s at 58 °C and 30 s at 72 °C. Prod-
uct specificity was determined by melting curve analysis.
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Chromatin immunoprecipitation (ChIP) analysis
Cells were cultured in 10 cm dishes and then infected with 
T. gondii for the indicated times. ChIP was performed 
according to manufacturer’s recommendations (ChIP-
IT Express enzymatic kit, Active Motif, CA, USA). The 
supernatant containing the sheared chromatin was incu-
bated with anti-UHRF1 or anti-Actin (as negative con-
trol) antibody and magnetic beads overnight at 4 °C on a 
roller shaker. The beads were washed and incubated with 
100 µl of elution buffer at 65 °C for 2.5 h. Cross-linking 
was reversed by a 1.5 h incubation with 2 µl of protein-
ase K at 37 °C. DNA was extracted using the QiaMini 
Kit (Qiagen). DNA samples from the ChIP experiments 
were subjected to PCR using CYCLINB1 promoter-specific 
primers (sense 5′-CGC CAA TGG GAA GGG AGT-3′, 
antisense 5′-CCA CAA GAC GAA GAG GGG C-3′) and 
TaqDNA polymerase (Invitrogen). The reaction contents 
were heated to 94 °C for 15 min for polymerase activation 
followed by 35 cycles at 94 °C for 30 s, 55 °C for 30 s, 
72 °C for 30 s and a final step at 72 °C for 7 min.
Methylation analysis
BeWo cells were cultured and infected in six-well plates, 
as described above. DNA was extracted using QiaMini 
Kit (Qiagen). Bisulfite conversion was performed using 
MethylDetector (Active Motif), according to the manu-
facturer’s recommendations. The modified DNA was then 
subjected to PCR amplifications of the repetitive LINE1 
sequence, using either primers specific for the methyl-
ated sequence (sense 5′-AAG ATG GTC GAA TAG GAA 
TAG-3′, antisense 5′-CAC TCC CTA ATA AAA TAA 
ACC-3′) or for the unmethylated sequence (sense 5′-AGA 
TGG TTG AAT AGG AAT AGT-3′, antisense 5′-CAC 
TCC CTA ATA AAA TAA ACC-3′), at an annealing tem-
perature of 55 °C. Cycle numbers were optimized to stop 
the reaction in the logarithmic phase of amplification. 
Quantity One 4.6.5 software (Bio-Rad, Philadelphia, PA) 
was used for measuring the density of PCR bands.
DNMT assay
BeWo cells were cultured in six-well plates and then 
infected with T. gondii for the indicated times. DNMT 
activity was performed on 10 µg of nuclear extract using 
DNMT activity (Active Motif), according to manufactur-
er’s recommendations. Absorbances were read at 450 nm. 
As T. gondii was shown not to possess DNMT activity 
[31], these results fully represent host cell DNMT activity.
Statistical analysis
Statistical analysis was performed using Student’s t test for 
comparisons between two groups, or one-way ANOVA fol-
lowed by Dunnett’s post-test for comparisons relative to a 
control group. All tests were performed using GraphPad. A 
P value below 0.05 was considered statistically significant.
Results
Activation of UHRF1 promoter and phosphorylation 
of UHRF1 in T. gondii‑infected cells correlate 
with rhoptry secretion
We previously reported that UHRF1 expression is rapidly 
upregulated in T. gondii-infected trophoblastic BeWo cells 
[28], specialized cells of placental origin that have a central 
position in the control of materno-fetal passage of patho-
gens, including T. gondii [32]. Here, we wanted to study 
the kinetics of UHRF1 promoter activation and mRNA 
expressions upon T. gondii infection. First, host cells were 
transfected with an UHRF1 promoter-luciferase (UHRF1-
luc) reporter plasmid, followed by infection with the viru-
lent RH strain of T. gondii. Infection significantly induced 
UHRF1 promoter activity at 3 h post-infection (Fig. 1a). 
To complete this result, UHRF1 mRNA was analyzed by 
quantitative reverse transcription PCR. The results also show 
a significant increase in UHRF1 mRNA expression at 3 h 
post-infection (Fig. 1b). UHRF1 promoter activity did also 
increase in non-infected cells with culture time, but slower 
and not to the same extent as in infected cells (Suppl. Fig. 1).
We also examined the effect of T. gondii infection on 
UHRF1 promoter activity and cell cycle inhibition in astro-
cytes, primary targets of T. gondii in the brain [33]. We also 
observed an increase of UHRF1 promoter activity, but more 
gradual between 0 and 12 h of infection (Suppl. Fig. 2), in 
contrast to the sharp early peak seen in BeWo cells, as well 
as a visible, but less pronounced cell cycle block.
In the early phases of T. gondii invasion, rhoptry proteins 
are released into the host cell and modulate some of its pro-
cesses. Some of them present kinase activity, and are crucial 
in the host–pathogen interactions [10, 34]. To investigate the 
role of these secreted proteins, we pretreated the parasites 
with cytochalasin D, which allows rhoptry protein discharge 
into the cell, but not host cell penetration of the parasite 
[35]. As shown in Fig. 1c, cytochalasin D-treated T. gondii 
were still able to stimulate UHRF1 promoter activity at 3 h 
of infection. These data strongly suggest that Toxoplasma-
mediated activation of the UHRF1 promoter does not need 
parasite penetration of the host cell, but may be promoted 
by rhoptry secretion into the target cells. We also looked for 
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UHRF1 expression on the protein level following T. gon-
dii infection, with or without cytochalasin D pre-treatment. 
Six hours post-infection, UHRF1 protein expression was 
increased in the presence or not of cytochalasin D. These 
results confirmed that the increase in UHRF1 expression is 
due to rhoptry secreted proteins and does not need parasite 
penetration.
ROP16‑dependent activation and phosphorylation 
of UHRF1
To further characterize the interactions between T. gondii 
proteins and UHRF1, we employed the yeast two-hybrid 
technique to look for candidate proteins. The sequences of 
the strongest confirmed, non-redundant UHRF1-interacting 
clones were analyzed with bioinformatic tools, including 
ToxoDB (ToxoDB.org release 2.3) (data not shown). Several 
parasite proteins were identified, of which we selected the 
kinase ROP16 as the most likely candidate due to its role in 
parasite virulence and its demonstrated catalytic activity. We 
hypothesized that ROP16 might increase UHRF1 promoter 
activity and phosphorylate UHRF1.
To analyze if UHRF1 could be an as yet unknown sub-
strate of the ROP16 kinase, we infected BeWo cells with 
an RH mutant deficient for ROP16 (RHΔROP16). Intracel-
lular replication of RHΔROP16 parasites was similar to 
that of the RH WT parasites (data not shown). As shown 
in Fig. 2a and b, the UHRF1 promoter was not activated in 
cells infected with RHΔROP16 parasites, and UHRF1 pro-
tein expression was not increased in these cells, in contrast 
to cells infected with RH WT parasites.
We have previously shown that, contrary to its promoter 
activity, UHRF1 protein levels continuously increase up to 
24 h post-infection [28]. Therefore, we hypothesized that 
T. gondii might induce post-translational modifications of 
the UHRF1 protein to stabilize it. Phosphorylation is an 
essential process in regulating the activity of nuclear pro-
teins. Phosphorylation of UHRF1 increases its binding to 
the promoters of target genes [36]. Therefore, we examined 
Fig. 1  T. gondii infection acti-
vates UHRF1 promoter activity 
and phosphorylates UHRF1. 
a BeWo cells were transfected 
with UHRF1-promoter-lucif-
erase reporter plasmid for 24 h, 
then infected for the indicated 
times with T. gondii (RH strain) 
at a ratio of 1:1 and assessed for 
luciferase activity (mean ± SEM 
of three separate experiments 
performed in triplicate). 
*P < 0.05, compared to control. 
b BeWo cells were infected for 
the indicated times. UHRF1 
mRNA was quantified by 
reverse transcription and real-
time PCR (mean ± S.E.M. of 
three separate experiments per-
formed in triplicate). *P < 0.05, 
compared to control. c UHRF1 
promoter activity in BeWo cells 
was assessed as above following 
infection with T. gondii pre-
treated or not with cytochalasin 
D. Mean ± SEM of three sepa-
rate experiments performed in 
triplicate. *P < 0.05, compared 
to control. d Western blot analy-
sis of UHRF1 protein expres-
sion in BeWo cells infected with 
T. gondii pretreated or not with 
cytochalasin D. Actin served 
as a loading control. Data are 
representative of at least three 
independent experiments
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the phosphorylation of UHRF1 by immunoprecipitation of 
total UHRF1 protein and subsequent detection using an anti-
body against pan-phosphorylated serine (P-Ser). A twofold 
increase of phosphorylated UHRF1 was detected upon infec-
tion with RH WT, whereas this increase was less obvious 
with RHΔROP16 parasites (Fig. 2c). These results suggested 
that ROP16 is probably not the only, but a major factor for 
UHRF1 phosphorylation and activation.
To further investigate the influence of ROP16 and its cat-
alytic kinase domain, a plasmid containing the gene coding 
for a ROP16 mutant without a functional catalytic domain 
(ROP16ΔCat) was transfected into BeWo cells. Cells were 
also transfected with a plasmid containing the corresponding 
Fig. 2  T. gondii ROP16 is 
responsible for UHRF1 activa-
tion and phosphorylation. a 
BeWo cells were transfected 
with UHRF1-dependent 
luciferase reporter plasmid for 
24 h, then infected with the RH 
WT or RHΔROP16 strains for 
the indicated times. Luciferase 
activities were analyzed and 
shown as mean ± SEM of three 
separate experiments per-
formed in triplicate. *P < 0.05, 
**P < 0.01, compared to 0 h. 
b Cells were infected for 6 h 
with RH WT or RHΔROP16 
strains. Whole cell lysates were 
analyzed by Western blot using 
anti-UHRF1 antibodies. Actin 
served as a loading control. 
Data are representative of at 
least three independent experi-
ments. c Immunoprecipitation 
of UHRF1 was performed on 
whole cell lysates of uninfected 
or 6 h infected cells followed 
by Western blot analysis of the 
indicated proteins. The quantita-
tive graphs in (b) and (c) show 
the relative changes at 6 h of 
infection, compared to 0 h 
(mean ± SEM of three separate 
experiments). *P < 0.05, com-
pared to non-infected cells
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RH wild-type ROP16 and with an empty plasmid as control. 
As shown in Fig. 3a, overexpression of wild-type ROP16, 
but not ROP16ΔCat induced significant activation of the 
UHRF1 promoter.
Again, we also examined the effect of transfection of 
wild-type and mutant ROP16 on UHRF1 promoter activ-
ity in astrocytes We obtained similar results as in BeWo 
cells, with activation of UHRF1 promoter activity only upon 
transfection with the wild-type ROP16, but not ROP16ΔCat 
(Suppl. Fig. 3).
Together, these results demonstrate that ectopic expres-
sion of ROP16 is sufficient to activate UHRF1 promoter 
activity and that this activation depends on ROP16 kinase 
activity.
A single ROP16 amino acid determines 
the strain‑specific activation of UHRF1
The genus Toxoplasma consists of only one species, T. gondii, 
but the parasite population is extremely diverse. For ROP16, 
the decisive difference between virulent and avirulent alleles 
for STAT3 activation has been localized to the presence of 
leucine or serine, respectively, at position 503 [13]. To test this 
hypothesis on UHRF1, different types of ROP16 mutants from 
different strains were produced. The ROP16 503 leucine of 
type I (RH) and the atypical strain LEF were replaced by ser-
ine, and vice versa for the type II strain (PRU) ROP16, where 
serine was replaced by a leucine at the same position. As 
shown in Fig. 3b, RH and LEF 503 mutant plasmids induced 
less activation of the UHRF1 gene promoter than their wild-
type counterparts, while the PRU 503 mutant protein activated 
the UHRF1 gene promoter significantly stronger than the PRU 
wild type.
We next analyzed UHRF1 in cells expressing the same WT 
or 503 ROP16 mutant proteins on the protein level and got 
similar results (Fig. 3c). Expression of the PRU 503 ROP16 
mutant strongly increased UHRF1 protein levels. Taken 
together, these results suggest that this single locus on amino 
acid at 503 determines the impact of ROP16 on UHRF1 
expression.
Fig. 3  A single ROP16 amino acid determines the strain-specific 
activation of UHRF1. a BeWo cells were transfected with UHRF1-
promoter-luciferase reporter plasmid for 24  h, then with ROP16 
WT, ROP16 mutant plasmid without the catalytic kinase domain 
(ROP16ΔCat) (both from T. gondii RH strain) or the empty con-
trol plasmid. Luciferase activity was then analyzed and shown as 
mean ± SEM of three separate experiments performed in tripli-
cate. *P < 0.05, compared to control. b UHRF1 promoter activity 
in BeWo cells was assessed as above following transfection with 
one of the following plasmids: control plasmid (gray bar), ROP16 
WT plasmids (black bars) or ROP16m503 mutant plasmids (white 
bars) from PRU, LEF and RH strains. Mean ± SEM of three sepa-
rate experiments performed in triplicate. *P < 0.05, between ROP16 
WT and ROP16m503. c Western blot analysis of UHRF1 expression 
in cells transfected for 24 h with the control plasmid, ROP16 WT or 
ROP16m503 mutant plasmids from PRU, LEF or RH strains. Actin 
served as a loading control. Data are representative of at least three 
independent experiments
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UHRF1 is recruited to the cyclin B1 gene 
promoter and suppresses its expression 
in Toxoplasma‑infected cells
We have previously reported that UHRF1 is exploited by 
T. gondii to control CCNB1 gene expression. In T. gondii-
infected cells, increased levels of UHRF1 inversely correlate 
with levels of cyclin B1, leading to cell cycle dysregulation. 
mRNA levels of UHRF1 and cyclin B1 paralleled protein 
levels, meaning that these variations reflect changes in gene 
transcription [28]. To further establish whether UHRF1 is 
necessary and sufficient for CCNB1 silencing, we transfected 
BeWo cells with UHRF1-siRNA plasmids in the presence 
or absence of T. gondii and evaluated cyclin B1 expression 
(Fig. 4a). Cells transfected with an EGFP-siRNA expression 
plasmid were used as controls. We observed a reversal of 
the infection-induced cyclin B1 kinetics in UHRF1 knock-
down cells. A significant increase in cyclin B1 levels was 
observed at 12 h of infection in UHRF1 knock-down cells, 
compared with cells transfected with EGFP-siRNA, whereas 
lower expression is seen for earlier time points. These results 
indicate that UHRF1 is involved in cyclin B1 deregulation 
in T. gondii-infected cells.
To establish if UHRF1 is directly involved in cyclin B1 
downregulation, we examined the recruitment of UHRF1 
to the CCNB1 promoter during infection, by chromatin 
immunoprecipitation (ChIP) assay (Fig. 4b). We observed 
enhanced UHRF1 binding to the CCNB1 promoter at 3 h of 
infection. Control PCRs using primers for GAPDH cDNA 
demonstrated the specificity of UHRF1 precipitation (Suppl. 
Fig. 4). Together, these results show that, during T. gondii 
infection, UHRF1 negatively regulates cyclin B1 expression 
through recruitment on the CCNB1 promoter.
UHRF1 interacts with a multienzymatic complex 
on the cyclin B1 promoter to induce histone 
modifications
Following our previous finding that T. gondii downregu-
lates cyclin B1 expression through UHRF1 activation and 
considering the established role of UHRF1 in epigenetic 
modification, we hypothesized that it might regulate cyclin 
B1 expression by interfering with the epigenetic machin-
ery. UHRF1 is part of a multienzymatic chromatin-modi-
fying complex [37]. To further characterize these UHRF1 
containing immune complexes in T. gondii-infected cells, 
we immunoprecipitated UHRF1 at different time points 
and identified binding partners by mass spectrometry-
based proteomics. SDS-PAGE gel of cell lysates, stained 
by Coomassie blue is presented in supplementary data 
(Suppl. Fig. 5). Altogether, 474, 564, 1063, 512 and 399 
proteins were identified at t = 0 h, t = 1 h, t = 3 h, t = 6 h 
and t = 12 h, respectively (Suppl. Fig. 6). Seven proteins 
implicated in cell cycle control were identified at different 
time points (Fig. 5). All binding UHRF1 partners were 
validated by immunoprecipitation (data not shown). As 
shown in Fig. 5, we observed time-dependent interactions 
with the epigenetic-related proteins HDAC1 and HDAC2, 
PCNA, DNMT1, USP7, and HP1β.
Fig. 4  UHRF1 regulates cyclin B1 expression in T. gondii-infected 
cells. a BeWo cells were transfected with UHRF1-siRNA or EGFP-
siRNA plasmid vectors and infected for the indicated times with T. 
gondii at a ratio of 1:1. UHRF1, cyclin B1 and actin proteins were 
then analyzed by Western blot. Data are representative of at least 
three independent experiments. b Binding of UHRF1 to CCNB1 pro-
moter in infected cells. BeWo cells were infected with T. gondii for 
the indicated times at a moi of 4:1. ChIP assay was performed using 
antibodies against UHRF1, or actin as negative control. Immunocom-
plexes were then analyzed by real-time PCR specific for the promoter 
region of CCNB1. Non-immunoprecipitated chromatin material was 
used as input control. The results were normalized to the input DNA 
and expressed as relative binding, compared to non-infected cells. 
Data are mean ± SEM of three separate experiments. *P < 0.05, com-
pared to non-infected cells
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We hypothesized that these interactions with histone dea-
cetylases and methyltransferases might affect the histone 
marks on the CCNB1 promoter in the course of infection. To 
clarify these time-dependent changes, ChIP assays were per-
formed using antibodies against acetyl-H3 and H3K9me3, 
followed by CCNB1-specific PCR. We found a decrease 
of acetyl-H3 on the CCNB1 promoter at 6 h post-infection 
(Fig. 6a), paralleled by an increase of H3K9 trimethylation 
(Fig. 6b). These results indicate that HDAC and methyltrans-
ferases, recruited with UHRF1 to the CCNB1 promoter after 
infection, induce specific changes in histone acetylation and 
methylation levels.
T. gondii activates DNMT expression in infected cells 
and regulates gene expression via DNA methylation
To get insight into the potential mechanisms of altered meth-
ylation status in infected cells, we determined the expression 
levels of the different DNMTs in T. gondii-infected cells. 
DNMT1 maintains the methylation pattern during replica-
tion, while DNMT3a and DNMT3b are de novo methyl-
transferases [38]. Our previous results led us to hypothesize 
that T. gondii could modulate DNMT activity to epigeneti-
cally silence the expression of target genes. We examined 
global DNMT activity in infected cells (Fig. 7a). Indeed, 
a significantly increased DNMT activity was evident as 
early as 3 h of infection. Quantitative RT-PCR analysis 
revealed that expression levels of DNMT1 were increased 
by parasite infection (Fig. 7b). In addition, to examine the 
T. gondii infection global methylation status, we performed 
a methylation-sensitive PCR of LINE sequences which are 
dispersed throughout the genome. As shown in Fig. 7c, 
methylated LINE sequences increased with infection, 
while unmethylated sequences decreased at the same time. 
Together, these results support our hypothesis that T. gondii 
infection induces hypermethylation of host genome DNA by 
Fig. 5  UHRF1 recruits a multienzymatic complex in T. gondii-
infected cells. BeWo cells were infected with T. gondii for the indi-
cated times at a ratio of 1:1. Whole protein cell lysates were separated 
by SDS-PAGE. Gel slices were cut in a systematic way and proteins 
were reduced, alkylated, and digested. The resulting peptides were 
analyzed by nanoLC-MS/MS. Proteins were identified through data-
base searching, using a mixed human and toxo decoy database with a 
1% false discovery rate. MS/MS spectra of the seven proteins of inter-
est were extracted and manually validated to confirm the identifica-
tions
Fig. 6  T. gondii interferes with histone H3 acetylation and methyla-
tion on cyclin B1 promoter. BeWo cells were infected for the indi-
cated times with T. gondii at a moi of 1:1. ChIP assay was performed 
using antibodies against acetyl-histone 3 a and trimethyl-H3 (Lys9) b 
or an isotype control antibody. The precipitated DNA was then ampli-
fied by real-time PCR for CCNB1 promoter region. The results were 
normalized to the input DNA and expressed as relative binding, com-
pared to non-infected cells. Data are mean ± SEM of three separate 
experiments. *P < 0.05, compared to non-infected cells
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increasing mediation by DNMT1 mRNA, protein levels and 
the global DNMT activity.
T. gondii ROP16 kinase affects cyclin B1 expression 
and host cell cycle modulation
Our previous results show an UHRF1-mediated regulation of 
T. gondii-infected cell cycle. To analyze the role of ROP16 in 
this process, we infected cells with RH WT and RHΔROP16 
strains, and analyzed cyclin B1 expression levels and cell 
cycle (Fig. 8a, b). Infection with RHΔROP16 parasites did 
not result in decreased cyclin B1 expression, in contrast to 
the RH WT strain. Moreover, no augmentation of cells in 
G2/M phase was observed when infected with RHΔROP16 
Toxoplasma strain, again in contrast to the RH WT strain. 
Percentages of cells in the different cell cycle phases during 
RHΔROP16 infection are shown in Suppl. Figure 7. Together, 
these results indicate that cyclin B1 and UHRF1-dependant 
cell cycle regulation in infected cells are ROP16 dependent.
Discussion
The cell cycle is a target for intracellular microorganisms. 
For example, in HIV infection, cell cycle dysregulation is 
associated with enhanced virus proliferation [39]. We and 
others demonstrated such mechanisms with T. gondii infec-
tion, which induces an inhibition of cellular proliferation 
through arrest of the host cell cycle in the G2 phase via 
UHRF1 activation [28, 40]. The benefit of this modulation 
for the parasite remains unknown. Previous studies indi-
cated an optimized nutrient acquisition or a compromised 
mitosis by parasite-induced rearrangement of host cell 
microtubules and recruitment of the microtubule organiz-
ing center to the parasitophorous vacuole membrane [41]. 
We previously showed that the cell cycle arrest is linked 
to a downregulation of CCNB1 gene expression, associ-
ated with an overexpression of UHRF1 [28]. However, the 
parasitic factors inducing UHRF1 activation as well as the 
mechanisms of cell cycle regulation were unknown. Some 
authors hypothesized interactions between parasite proteins 
that cross the parasitophorous vacuole membrane and cyc-
lin/CDK complexes that may affect their catalytic activities 
[40]. Recently, overexpression of the parasite kinase ROP16 
was shown to be involved in Ser15/37 phosphorylation of 
p53, partial apoptosis of SH-SY5Y cells and cell cycle 
arrest in G1 stage [37]. We show here that ROP16 is one 
of the factors responsible for the UHRF1 activation, which 
in turn causes the down-regulation of cyclin B1 and the G2 
cell cycle arrest. We demonstrate that activated UHRF1 
is recruited to the CCNB1 promoter during infection and 
induces epigenetic modifications, resulting in the formation 
Fig. 7  T. gondii induces DNMT 
expression and methylation 
activity. a The global DNMT 
activity during infection was 
analyzed by an ELISA-based 
method, as detailed in the 
methods section. b Cells were 
infected for the indicated times 
with T. gondii at a ratio of 1:1. 
DNMT1 mRNA levels were 
quantified by RT-PCR and 
presented relative to GAPDH 
expression. c BeWo cells were 
infected with T. gondii at. DNA 
was extracted and subjected to 
bisulfite treatment. Methyla-
tion of the LINE1 sequence was 
assessed by PCR specific for 
methylated (M) or unmethyl-
ated (UM) sequences. Data are 
mean ± SEM of three separate 
experiments. *P < 0.05, com-
pared to non-infected cells
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of a heterochromatin environment and repression of the 
CCNB1 promoter activity. This is the first report demon-
strating that a parasitic infection, via its kinase ROP16, acti-
vates a transcription factor, UHRF1, leading to an epigenetic 
regulation process.
UHRF1 is a multi-domain-containing protein involved 
in epigenetic regulation through DNA methylation, histone 
deacetylation and methylation, and likely histone ubiquit-
ination [23, 24]. To determine with which partners UHRF1 
interacts with after T. gondii infection, we analyzed the enzy-
matic complexes associated with UHRF1 by mass spectrom-
etry. Our results in infected cells show that UHRF1 interacts 
with HDAC1 and 2, and DNMT1 to form a repressive com-
plex. Recruitment of this enzymatic complex leads to dea-
cetylation of histone H3 and methylation of histone H3K9 
on the CCNB1 promoter, and consequently to its silencing. 
Besides histone modification, we also show that T. gondii 
infection causes DNA hypermethylation in the host cell 
by upregulation of DNMTs. H3K9 methylation and DNA 
methylation are well known to contribute to gene repression 
[37]. While this mechanism has never been described in a 
parasite infection model, in sporadic breast cancer, UHRF1 
was shown to induce DNA methylation, as well as histone 
deacetylation and methylation on the BRCA1 promoter by 
recruitment of an inhibitory transcriptional complex simi-
lar to the one we observed here [42]. The SRA domain of 
UHRF1 directly interacts with 5-hydroxymethylcytosine and 
hemi-methylated DNA and PCNA, which helps to recruit 
DNMT1 and stimulate its enzymatic activity [22, 43]. The 
TTD/PHD domains interact with methylated H3K9 which 
stimulates the enzymatic activity of H3K9 methyltrans-
ferases (H3K9MT) and thus methylation of adjacent H3K9, 
resulting in heterochromatin formation and gene silencing 
[24, 44].
During our mass spectrometry-based proteomics, we also 
show that UHRF1 interacts with USP7 in infected cells. 
USP7 (HAUSP) is a deubiquitylase that regulates DNMT1 
and UHRF1 stability [45]. It is also targeted by T. gondii 
GRA16, binding PP2A-B55 to modulate genes involved in 
metabolism, cell cycle progression, and p53 tumor suppres-
sor pathway [15]. Indeed, USP7 mediates deubiquitylation 
of UHRF1, preventing its proteasomal degradation. Moreo-
ver, UHRF1 is released from USP7 at the M phase of the cell 
cycle after its phosphorylation by CDK1-cyclin B1, leading 
to UHRF1 degradation [46]. Together with our results, this 
underlines once more the importance of cell cycle dysregu-
lation in infected cells for maintaining a sufficient level of 
UHRF1 activity for parasite proliferation.
Precise molecular mechanisms of UHRF1 domain inter-
action with the CCNB1 promoter in parasite-dependent 
epigenetic events still need to be explored. However, based 
on our data, a global modeling of this interaction can be 
proposed (Fig.  9a). T.  gondii modulates CCNB1 gene 
expression by interfering with methylation and histone 
modifications. The recruitment of UHRF1 to the CCNB1 
promoter induces deacetylation of histone H3, by recruit-
ment of HDAC 1 and 2. UHRF1 also recruits histone 
lysine methyltransferases which methylate the histone H3 
Fig. 8  ROP16 plays a central 
role in UHRF1-dependant 
cyclin B1 regulation. a BeWo 
cells were infected for the 
indicated times with T. gondii 
RH WT or RHΔROP16 strains 
at a ratio of 1:1. Samples were 
analyzed by Western blot using 
antibodies against cyclin B1 or 
actin as loading control. Bands 
of three blots were analyzed by 
densitometry. b BeWo infected 
with T. gondii RH WT or 
RHΔROP16 strains were ana-
lyzed for cell cycle progression 
by flow cytometry of propidium 
iodide. Data are mean ± SEM 
of three separate experiments 
*P < 0.05, compared to non-
infected cells
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and allow HP1β binding and heterochromatin formation. 
Finally, DNMTs are recruited by UHRF1 to methylate and 
silence the CCNB1 promoter, resulting in cell cycle arrest 
in G2 phase. There is a similar example of the co-repressor 
COUP-TF interacting protein 2 (CTIP2) inhibiting HIV-1 
gene transcription by recruiting a chromatin-modifying 
complex and by establishing a heterochromatic environ-
ment at the HIV-1 promoter in microglial cells, leading to 
HIV-1 silencing [47].
ROP16 is a polymorphic T. gondii protein kinase, tar-
geting the host cell nucleus and known to directly induce 
phosphorylation of STAT3 and STAT6 [9, 13]. We show 
here that ROP16 also targets UHRF1. Our results suggest 
that UHRF1 is phosphorylated by ROP16 as an early event 
in cell invasion. Yamamoto et al. demonstrated that sub-
stitution of a single amino acid at position 503 (at the ser-
ine–threonine kinase domain) of the ROP16 protein in RH 
and Me49 strains determined a change in their activation of 
STAT3 [34]. Confirming the before mentioned findings for 
STAT3, we show that only the virulent isotype of ROP16 
activates the UHRF1 gene promoter. This could be one clue 
to explain the mechanisms behind the striking differences on 
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Fig. 9  Model of UHRF1-mediated cyclin B1 repression in T. gondii-
infected cells. a In infected cells, the transcription factor UHRF1 
binds to the CCNB1 promoter where it recruits the histone dea-
cetylases HDAC1 and 2 to promote local deacetylation of histone 
H3. UHRF1 also recruits histone methyltransferases which induce 
dimethylation of histone H3 allowing the recruitment of heterochro-
matin protein 1 (HP1β). Finally, the DNA methyltransferase DNMT1 
is recruited inducing DNA methylation on the CCNB1 promoter and 
thus heterochromatin formation and CCNB1 gene silencing. b Model 
of Toxoplasma-induced regulation of cyclin B1 expression
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cytokine induction and parasite control between ROP16 iso-
types in our recent in vivo study [11]. Preliminary work on 
PRU (type II) parasites, which contain the avirulent ROP16 
isotype showed a graduate, but much less pronounced upreg-
ulation of UHRF1, while the cell cycle shows a considerably 
delayed (12–24 h) and less pronounced block, compared to 
type I infection (our own observation). This indicates that 
other factors besides ROP16 might interfere with host cell 
cycle, but they are likely to use other pathways and are obvi-
ously less effective. The in silico profile of the ROP16 pro-
tein of different strains should be explored, as Yamamoto 
et al. [13] had found that the residue at position 503 (leucine) 
in the RH strain is completely inaccessible to the substrate 
and that the cavity was larger for type II Me49 strain making 
the site more active.
Our results lead us to hypothesize that ROP16 injected 
early in infected cells phosphorylates UHRF1. In turn, 
phosphorylated UHRF1 translocates to the host nucleus 
and recruits the epigenetic complex leading to CCNB1 pro-
moter silencing and the observed cell cycle arrest in G2/M 
(Fig. 9b). As indicated by the lesser, but still visible increase 
of phosphorylated UHRF1 during RHΔROP16 infection, 
other p53-related mechanisms may be involved in the fine 
tuning of the cell cycle. Regulation in early stages of inva-
sion through ROP16 or later through the secretion of pro-
teins such as GRA16, GRA24 or MYR1 could maintain the 
non-replicative status of the cell [15, 29, 48].
Pathogen-induced alterations of host cell physiology aim 
to maximize its survival. Histone modifications and chro-
matin remodeling regulating gene expression should be 
key targets for intracellular parasites. In bacteria- or virus-
induced host gene reprogramming, targets are the MAPK, 
IFN and NF-κB signaling pathways [49]. Well known in 
cancer development [24, 42], but unknown in host–patho-
gen interactions, we show the role played by UHRF1 during 
Toxoplasma parasitic infection.
In summary, we demonstrate in our model of tropho-
blastic cells that T. gondii ROP16 kinase activates UHRF1, 
which in turn regulates CCNB1 epigenetic silencing through 
its recruitment on the CCNB1 promoter and correlates with 
cell cycle dysregulation in these cells. Our data suggest 
that CCNB1 epigenetic silencing is coordinated by UHRF1 
through both DNA and histone methylation. Adding to 
the known transcription factors activated during infec-
tion, NF-κB, c-Fos, EGR1, c-Myc, STAT3/6, HIF1-α or 
NFAT4A, we can now include UHRF1, which emerges as 
an important epigenetic initiator regulating gene expression 
in T. gondii-infected cells along with NF-κB, p53, c-Myc 
STAT and HIF1-α [17]. Most likely, CCNB1 is not the only 
gene targeted by UHRF1 and regulated in an epigenetic 
manner in infected cells, and further studies should broaden 
our understanding on this central transcription factor for T. 
gondii infection.
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